Direct activities to develop and obtain new customers, foster and maintain long term relationships with key corporate accounts, manage internal marketing and external sales activities, for successful introduction and growth of infection disease product line.

Marketing Manager – Clinical Marketing Department, Urinalysis (2008 – 2010)• Directed activities related to distribution of Sysmex UF1000i automated urine analyzer. Integrated rapid urine bacteria screening capability into company strategy for Microbiology Laboratory Automation.Marketing Manager – Clinical Marketing Department, Nucleic Acid Diagnostics and Infectious Disease Products (2001 – 2008)• Directed activities related to market penetration of FDA approved HIV viral load assay. Supported other activities related to nucleic acid diagnostic product line, including instrumentation and new product introductions.• Managed all activities for Microplate Retrovirus product line, maintaining dominant market position in HIV diagnostics and HTLV screening products, including instrumentation.

Product Manager, Nucleic Acid Diagnostics (1994 – 2001)• Introduced and created commercial awareness of OTC’s Nucleic Acid Diagnostics division in North America. Served as liaison between International Business Area (Netherlands) and North America Marketing and Sales.• Created and directed NASBA Marketing Group (nucleic acid sequence-based amplification) of two Associate Product Managers and one Technical Service representative to support sales (1994-1997). Assisted with and directed individual for development of a Pharmaceutical Strategic Plan that included negotiating and maintaining relationships with drug companies to collaborate on projects which aid in NASBA product commercialization (1997 – 1998).• Introduced first HIV-1 RNA QT (viral load) and HIV-1 RNA QL products in the U.S. and Canada. Developed sales and expense budget, forecasted product demand, created promotional and training materials and provided product technical support. Provided marketing input for product design specifications, intended use, and claims for FDA submission of quantitative HIV-1 viral load (under PMA review) and CMV mRNA assay (510k cleared).Manager Corporate Accounts, Corporate Accounts Development (1993 – 1994)As member of Corporate Accounts Department, responsible for corporate sales to major Buying Groups, Blood Bank Alliances, and Reference Laboratories.Sales Representative, Infectious Disease Sales Force (1991 – 1993)Associate Product Manager, Infectious Disease Marketing (1987 – 1991)

Various roles in R&D and Clinical Trials Dept